<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0000833'>Impaired glucose tolerance</z:hpo> (IGT) represents a <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">pre-diabetic</z:e> state </plain></SENT>
<SENT sid="1" pm="."><plain>Controversy continues in regards to its pathophysiology </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to investigate the differences in insulin sensitivity (IS) and secretion in <z:mp ids='MP_0001261'>obese</z:mp> adolescents with IGT compared with those with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT) and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: A total of 12 <z:mp ids='MP_0001261'>obese</z:mp> adolescents with NGT, 19 with IGT, and 17 with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> underwent evaluation of insulin sensitivity (3-h hyperinsulinemic [80 micro/m(2)/min]-euglycemic clamp), first-phase insulin and second-phase insulin secretion (2-h hyperglycemic clamp), body composition, and abdominal <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> disposition index (GDI) was calculated as the product of first-phase insulin x insulin sensitivity </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Insulin-stimulated <z:chebi fb="105" ids="17234">glucose</z:chebi> disposal was significantly lower in subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> compared with subjects with NGT and IGT, with no difference between the latter two </plain></SENT>
<SENT sid="6" pm="."><plain>However, compared with youth with NGT, youth with IGT have significantly lower first-phase insulin and C-<z:chebi fb="7" ids="16670">peptide</z:chebi> levels and GDI (P = 0.012), whereas youth with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> have an additional defect in second-phase insulin </plain></SENT>
<SENT sid="7" pm="."><plain>Fasting and 2-h <z:chebi fb="105" ids="17234">glucose</z:chebi> correlated with GDI (r = -0.68, P &lt; 0.001 and r = -0.73, P &lt; 0.001, respectively) and first-phase insulin but not with insulin sensitivity </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Compared with youth with NGT, <z:mp ids='MP_0001261'>obese</z:mp> adolescents with IGT have evidence of a beta-cell defect manifested in impaired first-phase insulin secretion, with a more profound defect in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> involving both first- and second-phase insulin </plain></SENT>
<SENT sid="9" pm="."><plain>GDI shows a significantly declining pattern: it is highest in NGT, intermediate in IGT, and lowest in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Such data suggest that measures to prevent progression or conversion from pre-<z:mp ids='MP_0002055'>diabetes</z:mp> to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> should target improvement in beta-cell function </plain></SENT>
</text></document>